Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH Role in Intestinal TRL Metabolism
NCT01572259Phase 3Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Sep 2011
- Primary completion
- Mar 2016
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, open-label trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Measure of Growth hormone at 3 years. Status: unknown.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01572259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01572259.